Hybrid Models for Biopharmaceutical Process Development – Making the Best of Mechanistic Know-How and Data-Driven Insights

Towards Virtual Biofactories Digitalization and AI provide biopharmaceutical companies with the key to innovation in product and process development. In the future, these technical advancements will make it possible to control data flows along the entire value chain and use modules to predict the be...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy